DELONG MARK JEFFREY (Senior Vice President) sold 4.1% of their position (3.37K shares) of APELLIS PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $73.4K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 1/23/2026ACC: 0001492422-26-000059
Officer· Senior Vice President
Since Mar 2021
-3.37K
Net shares
Net seller
$73.4K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
3.37K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−3.37K
Price / share
$21.77
Trade value
$73.37K
% of position
4.1%
1/22/2026
81.72K→78.35K
Total
Net shares
−3.37K
Net value
-$73.37K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/22/2026 | S · Sale | −3.37K | $21.77 | $73.37K | 4.1% | 81.72K | 78.35K |
| Total | −3.37K | -$73.37K | ||||||
Derivative Transactions0
No derivative transactions reported